SWX:NOVNPharmaceuticals
Is Novartis Trading Below Fair Value After Recent Price Swings in 2025?
Wondering if Novartis is still a smart buy, especially as markets search for true value in giant pharma stocks?
While shares have climbed 14.5% year-to-date and are up 13.5% over the last year, price swings like the recent 3.1% gain this week and 3.1% dip last month signal shifting investor moods.
This volatility comes as Novartis moves ahead with strategic initiatives, including its focus on innovative medicines and ongoing restructuring to sharpen its business. Headlines continue to...